Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis : a multicenter, double-blind, randomized controlled study - Supplementary Appendix

Name: Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis : a multicenter, double-blind, randomized controlled study - Supplementary Appendix
Creator: Ines TEJEDOR
Published: 2020-09-24T12:30:10.617Z
Keywords: Seborrheic Dermatitis

TEJEDOR, Ines; Joly, Pascal

doi:10.17632/y3hmp9nbty.1

Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis : a multicenter, double-blind, randomized controlled study - Supplementary Appendix

Published: 24 September 2020| Version 1 | DOI: 10.17632/y3hmp9nbty.1

Contributors:

Ines TEJEDOR, Pascal Joly

Description

Supplementary Appendix

Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis : a multicenter, double-blind, randomized controlled study - Supplementary Appendix

Description

Files

Categories

Licence